INVESTOR NEWS

  • Loading stock data...

Soaring Eagle Acquisition Corp. is a special purpose acquisition company founded by Harry Sloan, Jeff Sagansky, and Eli Baker.

Biogen and Ginkgo Bioworks Announce Collaboration and License Agreement to Develop Novel Gene Therapy Manufacturing Platform

  • Collaboration aims to develop a next-generation AAV production platform to help accelerate Biogen’s efforts to bring novel gene therapies to patients worldwide
  • Ginkgo’s synthetic biology expertise may enable the expansion of therapeutic utility and overcome development challenges of viral vectors for gene therapy
  • Ginkgo to receive $5 million upfront payment and is eligible for up to $115 million in potential research, development, and commercial milestones

CAMBRIDGE, Mass. and BOSTON, Mass. — May 21, 2021 – Biogen (Nasdaq: BIIB) and Ginkgo Bioworks today announced a gene therapy collaboration. Together, the companies aim to redefine the industry standard for manufacturing recombinant adeno-associated virus (AAV)-based vectors.

Read More

Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming

BOSTON, MA and LOS ANGELES, CA May 11, 2021 — Ginkgo Bioworks, Inc. (“Ginkgo”) and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) (“Soaring Eagle”), a publicly traded special purpose acquisition company, have agreed to a business combination that will result in Ginkgo becoming a publicly-listed company.

Read More

Soaring Eagle Acquisition Corp., Led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about April 19, 2021

NEW YORK, NY April 15, 2021 — Soaring Eagle Acquisition Corp. (the “Company”), the seventh public acquisition vehicle led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker today announced that holders of the units sold in the Company’s initial public offering of 172,500,000 units completed on February 26, 2021

Read More

Soaring Eagle Acquisition Corp., Led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker Announces Completion of $1.725 billion IPO

NEW YORK, NY February 26, 2021 — Soaring Eagle Acquisition Corp. (the “Company”), the seventh public acquisition vehicle led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker today announced the closing of its initial public offering of 172,500,000 units, including 22,500,000 units issued pursuant to the exercise

Read More

Soaring Eagle Acquisition Corp., Led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker Announces Pricing of $1.5 billion IPO

NEW YORK, NY February 23, 2021 — Soaring Eagle Acquisition Corp. (the “Company”), the seventh public acquisition vehicle led by Eagle Equity Partners’ Harry Sloan, Jeff Sagansky and Eli Baker today announced the pricing of its initial public offering of 150,000,000 units, at a price of $10.00 per unit. Each unit issued in the initial
Read More